InnAVasc Medical

Inn A Vasc Medical

Medical Devices, 110 Swift Ave, Durham, North Carolina, 27705, United States, 1-10 Employees

innavasc.com

  • facebook
  • LinkedIn

phone no Phone Number: 91********

Who is INNAVASC MEDICAL

InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The Compan...

Read More

map
  • 110 Swift Ave, Durham, North Carolina, 27705, United States Headquarters: 110 Swift Ave, Durham, North Carolina, 27705, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from INNAVASC MEDICAL

InnAVasc Medical Org Chart and Mapping

Employees

Peter Lawson

Bioengineering Consultant - Business Strategy and Product Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding InnAVasc Medical

Answer: InnAVasc Medical's headquarters are located at 110 Swift Ave, Durham, North Carolina, 27705, United States

Answer: InnAVasc Medical's phone number is 91********

Answer: InnAVasc Medical's official website is https://innavasc.com

Answer: InnAVasc Medical's revenue is $1 Million to $5 Million

Answer: InnAVasc Medical's SIC: 3841

Answer: InnAVasc Medical's NAICS: 339112

Answer: InnAVasc Medical has 1-10 employees

Answer: InnAVasc Medical is in Medical Devices

Answer: InnAVasc Medical contact info: Phone number: 91******** Website: https://innavasc.com

Answer: InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The Companys first technology is an arteriovenous graft (AVG) modification that incorporates two cannulation Pods, with low bleed technology, that are resistant to posterior and sidewall needle penetration and injury. The InnAVasc arteriovenous graft was designed to reduce the potential for adverse events and device failures associated with repeated vascular access.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access